Sponsored Links
| Biopure Submits IND Application For Proposed Clinical Trial In Patients With Acute Myeloid Leukemia |
 |
 |
 |
| Medical News - Lymphology and Lymphedema | |||
|
Biopure Corporation (Nasdaq: BPUR) announced that it has submitted to the Food and Drug Administration (FDA) an investigational new drug (IND) application to conduct a pilot phase 2 clinical trial of the company's oxygen therapeutic Hemopure(R) [hemoglobin glutamer - 250 (bovine)]. Read more: Lymphology/Lymphedema News From Medical News Today
|